Cite
MLA Citation
Matthew Rausch et al.. “727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A435. http://access.bl.uk/ark:/81055/vdc_100144715863.0x000003